Pola Tatalaksana Farmakologis Hipertensi pada Pasien Rawat Inap di RS dr Soedirman Kebumen
DOI:
https://doi.org/10.18196/mm.190121Keywords:
Hipertensi, Tatalaksana Farmakologis, Rawat InapAbstract
Rumah sakit menduduki posisi penting untuk tatalaksana hipertensi. Tatalaksana hipertensi yang baik di rumah sakit menyebabkan tekanan darah terkontrol. Kenyataan tatalaksana hipertensi di rumah sakit saat ini belum maksimal. Penelitian ini bertujuan untuk mengetahui gambaran pola tatalaksana farmakologis hipertensi pasien rawat inap di RS dr Soedirman Kebumen tahun 2015. Penelitian ini bersifat non eksperimental deskriptif, menggunakan data rekam medis pasien dengan hipertensi tahun 2015. Variabel yang diobservasi meliputi jenis obat antihipertensi, jumlah obat, dosis obat dan capaian terapi. Sebanyak 95 pasien hipertensi rawat inap masuk kriteria inklusi. Pasien meninggal kurang dari 24 jam setelah rawat inap tidak diikutkan dalam penelitian. Golongan Calcium Channel Blocker merupakan obat yang paling sering digunakan secara tunggal maupun kombinasi (70,53%.) Sebanyak 46% diberikan kombinasi dua jenis obat. Kombinasi tersering yang digunakan adalah Angiotensin Receptor Blocker + Calcium Channel Blocker. Hanya 30,53% pasien memenuh target tekanan darah saat pulang. Pola tatalaksana hipertensi di RS dr Soedirman Kebumen belum sesuai dengan JNC VIII yaitu pada pemilihan jenis dan jumlah obat berdasar stadium hipertensi. Tingkat keberhasilan terapi pada kelompok dengan komorbid sudah baik dibandingkan capaian WHO tetapi sebaliknya pada kelompok tanpa komorbid.References
WHO. Global Status Report on Noncommunicable Diseases 2010. Geneva: WHO. 2011.
WHO. A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis. Geneva: WHO. 2013.
Riskesdas. Riset Kesehatan Dasar 2013. Jakarta: Kementrian Kesehatan RI. 2013.
Setiawan Z. Prevalensi dan Determinan Hipertensi di Pulau Jawa Tahun 2004. Jurnal Kesehatan Masyarakat Nasional, 2006; 1 (2): 57-62.
Carretero OA, Oparil S. Essential Hypertension. Circulation, 2000; 101 (3): 329-335.
Cheung BMY, Cheung TT. Challenges in the Management of Hypertension in Asia. Eur Heart J Suppl, 2012; 14 (Supplement A): A37–A38.
Yogiantoro M. Hipertensi Esensial, dalam Buku Ajar Ilmu Penyakit Dalam. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam FK UI. 2006.
Lisheng L, Ji Guang W, Lansheng G, Guozhang L, Jan AS. Comparison of Active Treatment and Placebo in Older Chinese Patients with Isolated Systolic Hypertension. J Hypertens, 1998; 16 (12): 1823–1829.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb D, Handler J, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA, 2014; 311 (5): 507-520.
Murinson M, Roth B, Grosman E, Dicker D, Elis A. Blood Pressure Control during Hospitalization at the Department of Medicine. Arch Clin Hypertens, 2015; 1 (1): 001-004.
Ervin SE. Hospital Management of Hypertension: Essential and Secondary Hypertension. Hospital Medical Practice. 2014; 2 (12): 1-14.
Banegas JR, Segura J, Ruilope LM, Luque M, García-Robles R, Campo C, et al. Blood Pressure Control and Physician Management of Hypertension in Hospital Hypertension Units in Spain. Hypertension, 2004; 43 (6): 1338-1344.
JNC -8. The Eight Report of the Joint National Committee. Hypertension Guidelines: An In-Depth Guide. Am J Manag Care, 2014; 20 (1 Spec No.): E8.
Sedayu B, Azmi S, Rahmatini. Karakteristik Pasien Hipertensi di Bangsal Rawat Inap SMF Penyakit Dalam RSUP DR. M. Djamil Padang Tahun 2013. Jurnal Kesehatan Andalas, 2015; 4 (1): 65-69.
Chen Y, Hu S, Shen G, Wu L, Xu W, Wang L, et al. Antihypertensive Treatment among Inpatients with Hypertension at Anhui Provincial Hospital in China: a Cross-Sectional Study. Lat Am J Pharm, 2012; 31 (2): 298-304.
Nachiya RAM, Parimkrisnan S, Ramakrishna Rao M. Study of Drug Utilization Pattern of Antihypertensive Medications on Out-patients and Inpatiens in a Tertiary Care Teaching Hospital: A Cross Sectional Study. African J Pharm Pharmacol, 2015; 9 (11): 383-396.
Potchoo Y, Goe-Akue E, Damorou F, Massoka B, Redah D, Guissou IP. Effect of Antihypertensive Drug Therapy on the Blood Pressure Control among Hypertensive Patients Attending Campus’ Teaching Hospital of Lome, Togo, West Africa. Pharmacology & Pharmacy, 2012; 3 (1): 214-223.
Downloads
Published
Issue
Section
License
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
